Name: RenovoRx, Inc. (RNXT) Financial Statements
Creator: FinSpry

RenovoRx Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

RenovoRx, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.04	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.04	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	6.03	5.67	4.30	3.04	2.39
Selling, General & Administrative	4.99	5.73	5.65	2.63	0.82
Operating Expenses	11.01	11.40	9.95	5.67	3.20
Operating Income	-10.97	-11.40	-9.95	-5.67	-3.20
Other Income/Expense
Interest Income	0.38	0.11	0.06	0.00	0.00
Interest Expense	0.00	0.00	0.00	-0.83	-0.59
Other Income/Expense	1.77	-1.06	0.00	-0.18	-0.01
Income
Income Before Tax	-8.81	-10.23	-9.89	-6.32	-3.80
Income Tax Expense	0.00	-0.88	-0.92	-0.33	0.00
Net Income	-8.81	-10.23	-9.89	-6.32	-3.80
Net Income - Continuous Operations	-8.81	-10.23	-9.89	-6.32	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-10.97	-11.11	-9.88	-4.78	0.00
EBIT	-10.97	-11.11	-9.89	-5.49	-3.20
Depreciation & Amortization	0.00	0.01	0.01	0.01	0.00
Earnings Per Share
Basic EPS	-	-1.00	-1.00	-1.00	-2.00
Diluted EPS	-	-1.00	-1.00	-1.00	-2.00
Basic Shares Outstanding	22.27	10.29	9.05	5.22	2.21
Diluted Shares Outstanding	22.27	10.29	9.05	5.22	2.21